Novavax and Serum Institute of India Announce Development and Commercial Collaboration
06 août 2020 16h49 HE
|
Novavax, Inc.
Expected to support minimum of 1 billion doses of NVX-CoV2373 for India and low- and middle-income countriesLeverages Serum Institute’s existing reach and infrastructure Builds on and complements...
Novavax to Host Conference Call to Discuss Second Quarter Financial and Operating Results on August 10, 2020
06 août 2020 06h45 HE
|
Novavax, Inc.
GAITHERSBURG, Md., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX), a late stage biotechnology company developing next-generation vaccines for serious infectious diseases, today...
Novavax Announces Positive Phase 1 Data for its COVID-19 Vaccine Candidate
04 août 2020 16h05 HE
|
Novavax, Inc.
Phase 1 portion of the Phase 1/2 clinical trial evaluated two doses of Novavax’ COVID-19 vaccine across two dose levels (5 and 25 µg) in 131 healthy adults ages 18-59 yearsNVX-CoV2373 was generally...
Novavax and FUJIFILM Diosynth Biotechnologies Initiate Large Scale Manufacturing of COVID-19 Vaccine Candidate
23 juil. 2020 16h02 HE
|
Novavax, Inc.
GAITHERSBURG, Md. and MORRISVILLE, N.C., July 23, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious...
Novavax to Present COVID-19 Vaccine Candidate Progress at 2nd ISV COVID-19 Vaccines Virtual Congress
20 juil. 2020 16h05 HE
|
Novavax, Inc.
GAITHERSBURG, Md., July 20, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today...
Novavax Announces $1.6 Billion Funding from Operation Warp Speed
07 juil. 2020 06h00 HE
|
Novavax, Inc.
Funding supports late-stage clinical development, including pivotal Phase 3 clinical trial to support licensure OWS award funds large-scale manufacturing of NVX-CoV2373, including production of 100...
Novavax Announces Updates to Leadership Team
02 juil. 2020 08h30 HE
|
Novavax, Inc.
Frank Czworka appointed SVP, Global Sales Brian Webb promoted to SVP, Manufacturing GAITHERSBURG, Md., July 02, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology...
Novavax Expands Executive Leadership and Announces Key Promotions
29 juin 2020 08h42 HE
|
Novavax, Inc.
GAITHERSBURG, Md., June 29, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today...
Novavax to Participate in H.C. Wainwright Fireside Chat Series
24 juin 2020 08h00 HE
|
Novavax, Inc.
GAITHERSBURG, Md., June 24, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX), a late stage biotechnology company developing next-generation vaccines for serious infectious diseases, today...
Novavax Announces Additions to Executive Leadership
17 juin 2020 08h00 HE
|
Novavax, Inc.
GAITHERSBURG, Md., June 17, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today...